Customer support

xie@china-sinoway.com
EnglishEnglish
banner
Products
Home

API

Adenosine triphosphate disodium ATP 987-65-5

Adenosine triphosphate disodium ATP 987-65-5

99% up by HPLC
  • Product Details

Product Information


Product name

Adenosine triphosphate disodium / ATP

Synonyms

Adenosine-5'-triphosphate disodium trihydrate; 5'-ATP-Na2; ADENOSINE-5'-TRIPHOSPHATE DISODIUM SALT HYDR.,CALCIUM FREE; Adenosine-5'-triphosphate disodium salt hydrate,water; disodium adenosine 5'-triphosphate trihydrate;

CAS No.

987-65-5

Molecular Formula

C10H16N5O13P3.3H2O.2Na

Molecular Weight

607.21

Molecular Structure

Quality Standard

99% up by HPLC

Appearance

White to off-white powder


COA of Adenosine triphosphate disodium / ATP




Item

Specification

Results

Appearance

A white to off-white powder

Conforms

Identification

IR

Conforms

PH

2.5-3.5

3.03

Loss on drying

12.0%

7.72%

Fe+

0.001%

Conforms

Chloride (Cl)

0.05%

Conforms

Heavy metals

10 ppm

Conforms

Assay

99%

99.2%

Conclusion

The sample conforms to standard



Usage


Function and efficacy:

Adenosine triphosphate disodium is a nucleotide derivative involved in the metabolism of fat, protein, sugar, nucleic acid and nucleotides in the body. When the body needs energy for absorption, secretion, muscle contraction and biochemical synthesis reactions, adenosine triphosphate is decomposed into adenosine diphosphate and phosphate groups, and energy is released at the same time. Adenosine disodium triphosphate can penetrate the blood-cerebrospinal fluid barrier, improve the stability and reconstruction ability of nerve cell membranous structure, and promote the regrowth of neurites. This product and pentose can synthesize nucleic acid under the action of enzymes in vivo; and with phospholipid cholamine under the action of transcytidase, it can synthesize cephalin and cytidine monophosphate.


Indications:

Adjuvant therapy for progressive muscular atrophy, sequelae of cerebral hemorrhage, cardiac insufficiency, myocardial disease and hepatitis.


Combination efficacy:

Compound injection prepared with coenzyme A is used for hepatitis, nephritis, heart failure, etc.


Other effects:

Rapid supraventricular tachycardia, asthenopia, ophthalmoplegia, retinal hemorrhage, central retinitis, optic neuritis, optic atrophy.


*Products under the patent are only for R&D use


Send A Message

If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.
Related Products

Spironolactone
Spironolactone 52-01-7
EP8, USP38,99.95% up by HPLC, total impurities < 0.05%
Mupirocin powder
Mupirocin 12650-69-0
99% up by HPLC / GMP
Imatinib mesylate
Imatinib Mesylate 220127-57-1
In-house Standard
Ceftiofur sodium
Ceftiofur sodium 104010-37-9
In-house Specification
Thymopentin
Thymopentin 69558-55-0
99% up Medical Grade
Azilsartan
Azilsartan 147403-03-0
99% up, JP/ GMP / PMDA / DMF
Send A Message
Send A Message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.

Home

Products

about

Contact